AerCap Leased, Purchased and Sold 70 Aircraft in the Third Quarter 2015

Amsterdam, The Netherlands; October 14, 2015 - AerCap Holdings N.V. ("AerCap," NYSE: AER) today announced its major business transactions during the third quarter 2015:

  • Signed lease agreements for 46 aircraft, including 12 widebody and 34 narrowbody aircraft.
     
  • Purchased 7 aircraft, including 1 Boeing 787-8, 1 Boeing 787-9, and 5 Boeing 737-800s.
     
  • Executed sale and part-out transactions for 17 aircraft, including 2 Airbus A320-200s, 4 Airbus A330-200s, 1 Airbus A340-300, 2 Boeing 757-200s, 2 Boeing B777-200ERs and 2 Boeing B777-300ERs from AerCap's owned portfolio, and 1 Airbus A321-200, 1 Boeing 737 classic, 1 Boeing B757-200 and 1 MD-83 from AerCap's managed portfolio. We continue to manage 10 aircraft that were sold from our owned portfolio during the quarter.
     
  • Signed financing transactions for $0.4 billion. 

As of September 30, 2015, AerCap's portfolio consisted of approximately 1,730 aircraft that were either owned, managed, or under contract to purchase.

About AerCap

AerCap is the global leader in aircraft leasing and has one of the most attractive order books in the industry. AerCap serves over 200 customers in approximately 90 countries with comprehensive fleet solutions and provides part-out and engine leasing services through its subsidiary, AeroTurbine. AerCap is listed on the New York Stock Exchange (AER). The company is headquartered in Amsterdam and has offices in Dublin, Los Angeles, Shannon, Fort Lauderdale, Miami, Singapore, Shanghai, Abu Dhabi, Seattle, and Toulouse.

This press release may contain forward-looking statements that involve risks and uncertainties. In most cases, you can identify forward-looking statements by terminology such as "may", "should", "expects", "plans", "anticipates", "believes", "estimates", "predicts", "potential" or "continue" or the negative of such terms or similar terminology.  Such forward-looking statements are not guarantees of future performance and involve significant assumptions, risks and uncertainties, and actual results may differ materially from those in the forward-looking statements.